Podcast Episode Details

Back to Podcast Episodes
Cannabis Real Estate Debt, Evergreen REIT Structure and Risk-First Diligence ft. Chris Reece

Cannabis Real Estate Debt, Evergreen REIT Structure and Risk-First Diligence ft. Chris Reece


Season 1 Episode 4011


On this episode of the Passive Income Playbook, Pascal Wagner interviews Chris Reece about lending against cannabis-licensed real estate and why he underwrites properties to an alternative (non-cannabis) use to de-risk senior mortgages on stabilized assets. They dig into MJ REIT’s evergreen, 506(c) structure—monthly subscriptions/redemptions, no lockup, a $25k minimum—and its goal of double-digit annualized distributions (11.27% net since inception) paid monthly. Chris contrasts construction lending vs. stabilized assets, explains how federal illegality (Schedule I/280E, SAFE Banking stalls) shapes the opportunity, and why today’s “gray zone” may persist for several years even as state markets expand. The conversation closes with how LPs should diligence cannabis debt funds: team/IC depth, conservative LTVs, consistency through cycles, and alignment on risk.

Chris Reeze

  • Current role: Founder & CEO at MJ REIT

  • Based in: Greater Philadelphia Are

  • Say hi to them at: mj-reit.com, LinkedIn

    Visit investwithsunrise.com to learn more about investment opportunities. 

    Get 50% Off Monarch Money, the all-in-one financial tool at www.monarchmoney.com with code BESTEVER


    Join the Best Ever Community

     The Best Ever Community is live and growing - and we want serious commercial real estate investors like you inside. It’s free to join, but you must apply and meet the criteria.

     Connect with top operators, LPs, GPs, and more, get real insights, and be part of a curated network built to help you grow.

    Apply now at ⁠www.bestevercommunity.com⁠


Learn more about your ad choices. Visit megaphone.fm/adchoices


Published on 3 months, 2 weeks ago






If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate